INX-315

News alerts, weekly reports and conference planners

Company:

G1 Therap, Incyclix Bio

Drug class:

CDK2 inhibitor

Related drugs:

CCNE1 amplification	Ovarian Cancer	CCNE1 amplification	Ovarian Cancer	INX-315 Sensitive: C2 – Inclusion Criteria INX-315 Sensitive : C2	INX-315 Sensitive: C2 – Inclusion Criteria INX-315 Sensitive : C2
CCNE1 amplification	Gastric Cancer	CCNE1 amplification	Gastric Cancer	INX-315 Sensitive: D – Preclinical INX-315 Sensitive : D	INX-315 Sensitive: D – Preclinical INX-315 Sensitive : D

Associations
(2)